| LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer X Xue, YA Yang, A Zhang, KW Fong, J Kim, B Song, S Li, JC Zhao, J Yu Oncogene 35 (21), 2746-2755, 2016 | 441 | 2016 |
| LncRNA HOTAIR enhances the androgen-receptor-mediated transcriptional program and drives castration-resistant prostate cancer A Zhang, JC Zhao, J Kim, K Fong, YA Yang, D Chakravarti, YY Mo, J Yu Cell reports 13 (1), 209-221, 2015 | 342 | 2015 |
| Polycomb-and methylation-independent roles of EZH2 as a transcription activator J Kim, Y Lee, X Lu, B Song, KW Fong, Q Cao, JD Licht, JC Zhao, J Yu Cell reports 25 (10), 2808-2820. e4, 2018 | 293 | 2018 |
| Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program HJ Jin, JC Zhao, L Wu, J Kim, J Yu Nature communications 5 (1), 3972, 2014 | 191 | 2014 |
| FOXA1 inhibits prostate cancer neuroendocrine differentiation J Kim, H Jin, JC Zhao, YA Yang, Y Li, X Yang, X Dong, J Yu Oncogene 36 (28), 4072-4080, 2017 | 153 | 2017 |
| Genomic and evolutionary classification of lung cancer in never smokers T Zhang, P Joubert, N Ansari-Pour, W Zhao, PH Hoang, R Lokanga, ... Nature genetics 53 (9), 1348-1359, 2021 | 152 | 2021 |
| Estimated prevalence and clinical manifestations of UBA1 variants associated with VEXAS syndrome in a clinical population DB Beck, DL Bodian, V Shah, UL Mirshahi, J Kim, Y Ding, SJ Magaziner, ... Jama 329 (4), 318-324, 2023 | 148 | 2023 |
| Androgen receptor genomic regulation HJ Jin, J Kim, J Yu Translational andrology and urology 2 (3), 158, 2013 | 145 | 2013 |
| ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer L Wu, JC Zhao, J Kim, HJ Jin, CY Wang, J Yu Cancer research 73 (19), 6068-6079, 2013 | 121 | 2013 |
| Activation of MAPK signaling by CXCR7 leads to enzalutamide resistance in prostate cancer S Li, K Fong, G Gritsina, A Zhang, JC Zhao, J Kim, A Sharp, W Yuan, ... Cancer research 79 (10), 2580-2592, 2019 | 116 | 2019 |
| CD95/Fas increases stemness in cancer cells by inducing a STAT1-dependent type I interferon response AS Qadir, P Ceppi, S Brockway, C Law, L Mu, NN Khodarev, J Kim, ... Cell reports 18 (10), 2373-2386, 2017 | 106 | 2017 |
| Variable population prevalence estimates of germline TP53 variants: A gnomAD‐based analysis KC de Andrade, MN Frone, T Wegman‐Ostrosky, PP Khincha, J Kim, ... Human mutation 40 (1), 97-105, 2019 | 104 | 2019 |
| The prevalence of DICER1 pathogenic variation in population databases J Kim, A Field, KAP Schultz, DA Hill, DR Stewart International Journal of Cancer 141 (10), 2030-2036, 2017 | 96 | 2017 |
| FOXA1 potentiates lineage-specific enhancer activation through modulating TET1 expression and function YA Yang, JC Zhao, K Fong, J Kim, S Li, C Song, B Song, B Zheng, C He, ... Nucleic acids research 44 (17), 8153-8164, 2016 | 75 | 2016 |
| FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression JC Zhao, KW Fong, HJ Jin, YA Yang, J Kim, J Yu Oncogene 35 (33), 4335-4344, 2016 | 74 | 2016 |
| TMPRSS2–ERG gene fusions induce prostate tumorigenesis by modulating microRNA miR-200c J Kim, L Wu, JC Zhao, HJ Jin, J Yu Oncogene 33 (44), 5183-5192, 2014 | 66 | 2014 |
| Pathogenic germline variants in cancer susceptibility genes in children and young adults with rhabdomyosarcoma J Kim, N Light, V Subasri, EL Young, T Wegman-Ostrosky, DA Barkauskas, ... JCO Precision Oncology 5, 75-87, 2021 | 44 | 2021 |
| Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes LJ McReynolds, M Rafati, Y Wang, BJ Ballew, J Kim, VV Williams, W Zhou, ... Blood, The Journal of the American Society of Hematology 140 (8), 909-921, 2022 | 40 | 2022 |
| The prevalence of germline DICER1 pathogenic variation in cancer populations J Kim, KAP Schultz, DA Hill, DR Stewart Molecular Genetics & Genomic Medicine 7 (3), e555, 2019 | 36 | 2019 |
| Frequency of pathogenic germline variants in cancer-susceptibility genes in the Childhood Cancer Survivor Study J Kim, M Gianferante, DM Karyadi, SW Hartley, MN Frone, W Luo, ... JNCI Cancer Spectrum 5 (2), pkab007, 2021 | 35 | 2021 |